Fernando Palacios
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fernando Palacios has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Alejandra Perez-Chadid
Department of Neurosurgery, New Jersey Medical School, Rutgers University, Newark, USA
1 shared publication - Jerson Flores-Castillo
Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, La Victoria, Lima, Peru
1 shared publication - John Vargas-Urbina
Department of Neurosurgery, Skull Base and Functional Neurosurgery Units, National Institute of Neurological Sciences, Lima, Peru
1 shared publication - Jorge Zumaeta
Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru
1 shared publication - Jose Daniel Flores-Sanchez
Vascular, Tumors and Functional Neurosurgery Service - Department of Neurosurgery, Guillermo Almenara Irigoyen National Hospital, Lima, Peru
1 shared publication - Rommel Roger Rodriguez
Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru
1 shared publication
Latest Publications
- Open Access
- 22 December 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 440
Pandemic impact on aneurysmal subarachnoid hemorrhage in Peru’s high COVID-19 lethality setting: A public institutional experience
The COVID-19 pandemic in 2020 profoundly impacted healthcare worldwide, and Peru was particularly affected, experiencing the highest COVID-19 case fatality rate globally. We conducted a retrospective comparative study of patients presenting with aneurysmal subarachnoid hemorrhage (SAH) at a public Peruvian national referral center specializing in cerebrovascular diseases. Two study periods were considered, one during the first wave of the COVID-19 pandemic and a second identical period in 2019. Variables included patient demographics, comorbidities, COVID-19 infection status, clinical presentation, treatment approaches, and hospital outcomes. We analyzed 114 patients with aneurysmal SAH, 65 (57.0%) treated in 2019 and 49 (43.0%) in 2020. The mean time from emergency admission to the day of definitive treatment during 2019 and 2020 was 2.72 and 1.93 days, respectively. Likewise, the mean time from symptom onset to the date of definitive treatment was 6.71 and 7.70 days, respectively. We identified significant associations between complications such as sepsis, respiratory failure, acute kidney failure, and hospital mortality. The proportion of fatalities was significantly higher in 2020 compared to 2019 (36.7% vs. 15.4%, respectively). Interestingly, there was no statistically significant association between COVID-19 infection status and mortality during the 2020 period. Patients with aneurysmal SAH treated during the pandemic had a higher proportion of sepsis, respiratory failure, acute kidney failure, and mortality compared to the pre-pandemic period. Reallocating healthcare resources to prioritize COVID-19 patients may have inadvertently neglected or delayed care for patients with other emergency conditions, such as aneurysmal SAH. This highlights the importance of maintaining adequate care for non-infectious emergencies during a pandemic.
- 22 December 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 440
Open AccessPandemic impact on aneurysmal subarachnoid hemorrhage in Peru’s high COVID-19 lethality setting: A public institutional experience
The COVID-19 pandemic in 2020 profoundly impacted healthcare worldwide, and Peru was particularly affected, experiencing the highest COVID-19 case fatality rate globally. We conducted a retrospective comparative study of patients presenting with aneurysmal subarachnoid hemorrhage (SAH) at a public Peruvian national referral center specializing in cerebrovascular diseases. Two study periods were considered, one during the first wave of the COVID-19 pandemic and a second identical period in 2019. Variables included patient demographics, comorbidities, COVID-19 infection status, clinical presentation, treatment approaches, and hospital outcomes. We analyzed 114 patients with aneurysmal SAH, 65 (57.0%) treated in 2019 and 49 (43.0%) in 2020. The mean time from emergency admission to the day of definitive treatment during 2019 and 2020 was 2.72 and 1.93 days, respectively. Likewise, the mean time from symptom onset to the date of definitive treatment was 6.71 and 7.70 days, respectively. We identified significant associations between complications such as sepsis, respiratory failure, acute kidney failure, and hospital mortality. The proportion of fatalities was significantly higher in 2020 compared to 2019 (36.7% vs. 15.4%, respectively). Interestingly, there was no statistically significant association between COVID-19 infection status and mortality during the 2020 period. Patients with aneurysmal SAH treated during the pandemic had a higher proportion of sepsis, respiratory failure, acute kidney failure, and mortality compared to the pre-pandemic period. Reallocating healthcare resources to prioritize COVID-19 patients may have inadvertently neglected or delayed care for patients with other emergency conditions, such as aneurysmal SAH. This highlights the importance of maintaining adequate care for non-infectious emergencies during a pandemic.